Open AccessThe tale and trials of Efgartigimod: a newly FDA approved drug for the treatment of Myasthenia gravis
Author(s) -
Kashaf Waqar,
Anika Zainab
Publication year - 2022
Publication title -
journal of the pakistan medical association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.242
H-Index - 43
ISSN - 0030-9982
DOI - 10.47391/jpma.6388
Subject(s) - medicine , myasthenia gravis , drug , drug approval , clinical trial , drug trial , intensive care medicine , pharmacology